Meropenem Hikma

Meropenem, the active ingredient in Meropenem Hikma, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats severe bacterial infections, including intra‑abdominal, urinary, respiratory, and central nervous system infections, in hospitalized adults and children. GNH USA supplies Meropenem Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem antibiotic used for serious bacterial infections.

- Complicated intra‑abdominal infections: provides bacterial eradication and clinical cure in patients with intra‑abdominal sepsis. - Complicated urinary tract infections: eliminates resistant uropathogens and resolves infection. - Bacterial meningitis: penetrates the cerebrospinal fluid to treat meningitis caused by susceptible organisms. - Severe sepsis and septic shock: offers rapid bactericidal activity in critically ill patients. - Hospital‑acquired pneumonia: targets multidrug‑resistant pathogens in ventilated patients.

Adverse reactions may occur with meropenem therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal discomfort. - Diarrhea: may be watery and self‑limiting. - Rash: erythematous skin eruption at the infusion site. - Elevated liver enzymes: transient increase in ALT/AST. - Phlebitis: irritation of the vein used for infusion.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Anaphylaxis: acute hypersensitivity reaction requiring immediate intervention. - Clostridioides difficile colitis: severe diarrhea due to gut flora disruption. - Severe neutropenia: marked reduction in white blood cell count. - Renal toxicity: acute kidney injury in susceptible individuals.

Careful assessment and monitoring are required when using meropenem. - Renal function: adjust dose in patients with impaired clearance. - Seizure risk: monitor patients with a history of epilepsy or CNS disorders. - Allergy: avoid in individuals with known carbapenem hypersensitivity. - Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. - Drug interactions: review concomitant medications for possible interactions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with several concomitant drugs.

Major Interactions (Avoid): - Valproic acid: reduces plasma concentrations, increasing seizure risk. - Cytotoxic agents (e.g., cyclophosphamide): may enhance neurotoxicity. - Loop diuretics: can potentiate renal toxicity.

Moderate Interactions (Monitor Closely): - Aminoglycosides: additive nephrotoxic effect; monitor renal function. - Vancomycin: combined use may increase risk of kidney injury. - Anticoagulants (e.g., warfarin): may alter INR; monitor coagulation parameters.